KeyBank National Association’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

KeyBank National Association’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,977	Closed	-$217K	–	1114
2023 Q3	$217K	Hold	2,977	–	–	﹤0.01%	958
2023 Q2	$248K	Buy	+2,977	New	+$249K	﹤0.01%	951
2023 Q1	–	Sell	-2,652	Closed	-$220K	–	1098
2022 Q4	$220K	Buy	2,652 +75	+3%	+$6.07K	﹤0.01%	978
2022 Q3	$204K	Buy	+2,577	New	+$217K	﹤0.01%	985
2022 Q2	–	Sell	-2,465	Closed	-$222K	–	1135
2022 Q1	$222K	Sell	2,465 -400	-14%	-$36.9K	﹤0.01%	1003
2021 Q4	$321K	Buy	2,865 +13	+0.5%	+$1.57K	﹤0.01%	918
2021 Q3	$359K	Sell	2,852 -40	-1%	-$5.15K	﹤0.01%	894
2021 Q2	$392K	Sell	2,892 -18	-0.6%	-$2.37K	﹤0.01%	858
2021 Q1	$395K	Buy	2,910 +248	+9%	+$37.1K	﹤0.01%	854
2020 Q4	$375K	Hold	2,662	–	–	﹤0.01%	846
2020 Q3	$297K	Sell	2,662 -20	-0.7%	-$2.24K	﹤0.01%	834
2020 Q2	$300K	Hold	2,682	–	–	﹤0.01%	817
2020 Q1	$208K	Sell	2,682 -1,286	-32%	-$114K	﹤0.01%	851
2019 Q4	$377K	Buy	3,968 +966	+32%	+$83.6K	﹤0.01%	802
2019 Q3	$229K	Sell	3,002 -48	-2%	-$3.99K	﹤0.01%	902
2019 Q2	$268K	Buy	3,050 +100	+3%	+$8.53K	﹤0.01%	899
2019 Q1	$267K	Hold	2,950	–	–	﹤0.01%	857
2018 Q4	$212K	Hold	2,950	–	–	﹤0.01%	878
2018 Q3	$283K	Hold	2,950	–	–	﹤0.01%	921
2018 Q2	$281K	Buy	+2,950	New	+$271K	﹤0.01%	896
2013 Q3	–	Sell	-35,400	Closed	-$1.23M	–	1311
2013 Q2	$1.23M	Buy	+35,400	New	+$1.24M	﹤0.01%	735

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

CHP

Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

KeyBank National Association's XBI Position: Q4 2023 in Review

KeyBank National Association sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2023, closing a stake of 2,977 shares — an estimated $217K sold.

KeyBank National Association first reported a position in XBI in Q2 2013 and held it in 21 quarters. The position peaked at $1.23M in Q2 2013. 745 funds tracked by Wall St. Rank hold XBI as of Q4 2023.

KeyBank National Association reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2023 after selling out during the quarter.
KeyBank National Association sold 2,977 State Street SPDR S&P Biotech ETF shares in Q4 2023, an estimated $217K.
KeyBank National Association first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and held it in 21 quarters.
KeyBank National Association's State Street SPDR S&P Biotech ETF position peaked at $1.23M in Q2 2013.
745 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2023.

Based on KeyBank National Association's 13F filing for Q4 2023, filed 13 Feb 2024.